Akron Children's Logo
Skip to main content
Close Tools Menu Icon

Operator:

330-543-1000

Questions or Referrals:
ASK CHILDREN‘S

Close Phone Menu Icon
Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies

Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma

Full IRB Study Title:
Phase II Study of Denosumab (NSC# 744010), a RANK Ligand Antibody, for Recurrent or Refractory Osteosarcoma

IRB Study ID: 150914

For complete information, please view the study at clinicaltrials.gov

Study Sponsor:

Children's Oncology Group

Back to top of page

By using this site, you consent to our use of cookies. To learn more, read our privacy policy.